Embryotoxic doses of vitamin A to rabbits result in low plasma but high embryonic concentrations of all-trans-retinoic acid: risk of vitamin A exposure in humans.
Retinoid pharmacokinetics were examined in plasma, placenta and embryos of gestational d 12 rabbits following application of an embryotoxic dosing regimen (10 mg retinyl palmitate/kg body wt per day from gestational d 7 to 12). Vehicle-treated or untreated rabbits served as controls. Physiological concentrations of all-trans-retinoic acid (all-trans-RA) and 13-cis-RA in rabbit plasma (5-8.33 nmol/L) were very close to the endogenous levels in human plasma. In addition, we identified endogenous all-trans-RA, 3,4-didehydroretinol and 3,4-didehydroretinoic acid in rabbit embryo. Following the last retinyl palmitate administration, apparent steady-state concentrations of all retinoids were reached in the examined compartments of rabbits. The major polar retinoid in plasma was 9, 13-di-cis-RA, but its embryonic concentrations were only about 6% of those in plasma. In the embryo, retinol and its esters were found at high concentrations; lower amounts of all-trans-4-oxo-RA and the newly identified 14-hydroxy-4, 14-retro-retinol could also be measured. Embryonic concentrations of all-trans-RA were about 100% higher than endogenous levels. The overall exposure of the embryo to this retinoid was, however, substantial. Embryonic area under the concentration time curve values strongly suggest that the embryotoxicity of the applied dosing regimen is mainly due to the action of all-trans-RA. A very remarkable finding of this study is the marginal increase of plasma concentrations of all-trans-RA over their endogenous levels, which is comparable to the human situation after vitamin A intake. This analogy indicates that high vitamin A intake may be associated with a higher risk for teratogenic effects in humans even in the absence of high elevation of plasma all-trans-RA levels.
Tzimas
G
G
Institut für Toxikologie und Embryopharmakologie, Freie Universität Berlin, Germany.
Collins
M D
MD
Bürgin
H
H
Hummler
H
H
Nau
H
H
D000818:Animals; D004224:Diterpenes; D004305:Dose-Response Relationship, Drug; D004622:Embryo, Mammalian / Q000737:chemistry / Q000187:drug effects*; D005314:Embryonic and Fetal Development / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008431:Maternal-Fetal Exchange / Q000502:physiology*; D010920:Placenta / Q000737:chemistry; D011247:Pregnancy; D011817:Rabbits; D012176:Retinoids / Q000032:analysis / Q000097:blood; D000084562:Retinyl Esters; D013997:Time Factors; D014212:Tretinoin / Q000032:analysis* / Q000097:blood*; D014801:Vitamin A / Q000009:adverse effects / Q000031:analogs & derivatives / Q000032:analysis / Q000493:pharmacokinetics / Q000494:pharmacology / Q000633:toxicity*
D004224:Diterpenes; D012176:Retinoids; D000084562:Retinyl Esters; D014801:Vitamin A; C014794:retinol palmitate; D014212:Tretinoin